J. Goldman & CO LP Vanda Pharmaceuticals Inc. Transaction History
J. Goldman & CO LP
- $3.21 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding VNDA
# of Institutions
157Shares Held
44.9MCall Options Held
165KPut Options Held
33.6K-
Black Rock Inc. New York, NY8.14MShares$35.1 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.01MShares$17.3 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.63MShares$15.7 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.35MShares$10.1 Million0.94% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.26MShares$9.75 Million0.0% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $244M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...